Login / Signup

A Pilot Randomized Sham-Controlled Trial of MC5-A Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Thomas J SmithA Rab RazzakAmanda L BlackfordJennifer EnsmingerCatherine SaikiDenise Longo-SchoberleinCharles L Loprinzi
Published in: Journal of palliative care (2019)
We observed no difference between sham and real ST CIPN treatment. Potential reasons include at least the following: ST does not work; the sham treatment had some effect; small sample size with heterogeneous patients; misplaced electrodes on an area of nonpainful but damaged nerves; or a combination of these factors.
Keyphrases
  • chemotherapy induced
  • double blind
  • clinical trial
  • ejection fraction
  • combination therapy
  • risk assessment
  • prognostic factors
  • gold nanoparticles
  • chronic kidney disease
  • replacement therapy